Prelude Capital Management’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-9,672
| Closed | -$764K | – | 1444 |
|
|
2025
Q4 | $764K | Buy |
9,672
+5,523
| +133% | +$437K | 0.06% | 385 |
|
|
2025
Q3 | $342K | Buy |
4,149
+1,545
| +59% | +$122K | 0.03% | 665 |
|
|
2025
Q2 | $209K | Sell |
2,604
-355
| -12% | -$27.4K | 0.02% | 795 |
|
|
2025
Q1 | $238K | Buy |
+2,959
| New | +$246K | 0.02% | 822 |
|
|
2022
Q3 | – | Sell |
-20,997
| Closed | -$1.32M | – | 1791 |
|
|
2022
Q2 | $1.32M | Buy |
20,997
+9,506
| +83% | +$629K | 0.04% | 424 |
|
|
2022
Q1 | $808K | Buy |
+11,491
| New | +$777K | 0.02% | 668 |
|
|
2021
Q4 | – | Sell |
-17,241
| Closed | -$1.06M | – | 2141 |
|
|
2021
Q3 | $1.06M | Sell |
17,241
-19,871
| -54% | -$1.2M | 0.03% | 545 |
|
|
2021
Q2 | $2.22M | Buy |
37,112
+32,212
| +657% | +$2.04M | 0.07% | 263 |
|
|
2021
Q1 | $298K | Hold |
4,900
| – | – | 0.01% | 1152 |
|
|
2020
Q4 | $230K | Buy |
4,900
+656
| +15% | +$28.4K | 0.01% | 1043 |
|
|
2020
Q3 | $158K | Buy |
+4,244
| New | +$161K | 0.01% | 761 |
|
|
2020
Q2 | – | Sell |
-5,672
| Closed | -$173K | – | 2145 |
|
|
2020
Q1 | $173K | Buy |
+5,672
| New | +$252K | 0.01% | 478 |
|
|
2019
Q4 | – | Sell |
-8,945
| Closed | -$432K | – | 2118 |
|
|
2019
Q3 | $422K | Buy |
+8,945
| New | +$426K | 0.02% | 569 |
|
|
2019
Q2 | – | Sell |
-28,571
| Closed | -$1.34M | – | 1953 |
|
|
2019
Q1 | $1.22M | Buy |
+28,571
| New | +$1.26M | 0.07% | 283 |
|
|
2018
Q2 | – | Sell |
-23,867
| Closed | -$1.09M | – | 1823 |
|
|
2018
Q1 | $1.09M | Buy |
+23,867
| New | +$1.16M | 0.08% | 257 |
|
|
2016
Q4 | – | Sell |
-1,096
| Closed | -$43K | – | 1690 |
|
|
2016
Q3 | $43K | Buy |
1,096
+984
| +879% | +$37K | ﹤0.01% | 1093 |
|
|
2016
Q2 | $4K | Sell |
112
-13,806
| -99% | -$538K | ﹤0.01% | 1478 |
|
|
2016
Q1 | $545K | Buy |
13,918
+4,729
| +51% | +$177K | 0.08% | 290 |
|
|
2015
Q4 | $395K | Sell |
9,189
-253
| -3% | -$11.1K | 0.06% | 334 |
|
|
2015
Q3 | $397K | Buy |
9,442
+5,429
| +135% | +$254K | 0.06% | 332 |
|
|
2015
Q2 | $200K | Buy |
4,013
+2,891
| +258% | +$137K | 0.03% | 594 |
|
|
2015
Q1 | $51K | Buy |
+1,122
| New | +$50.4K | 0.01% | 1271 |
|
|
2014
Q4 | – | Sell |
-2,244
| Closed | -$107K | – | 2049 |
|
|
2014
Q3 | $107K | Hold |
2,244
| – | – | 0.02% | 1055 |
|
|
2014
Q2 | $111K | Hold |
2,244
| – | – | 0.01% | 1057 |
|
|
2014
Q1 | $106K | Buy |
+2,244
| New | +$103K | 0.01% | 1005 |
|
Other funds holding MET
VCM
VPM
Prelude Capital Management's MET Position: Q1 2026 in Review
Prelude Capital Management sold out of MetLife (MET) in Q1 2026, closing a stake of 9,672 shares — an estimated $764K sold.
Prelude Capital Management first reported a position in MET in Q1 2014 and held it in 25 quarters. The position peaked at $2.22M in Q2 2021. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.
- Prelude Capital Management reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
- Prelude Capital Management sold 9,672 MetLife shares in Q1 2026, an estimated $764K.
- Prelude Capital Management first reported a position in MetLife in Q1 2014 and held it in 25 quarters.
- Prelude Capital Management's MetLife position peaked at $2.22M in Q2 2021.
- 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.
Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.